Literature DB >> 26884490

The WHO's new End TB Strategy in the post-2015 era of the Sustainable Development Goals.

Knut Lönnroth1, Mario Raviglione2.   

Abstract

The WHO's new End TB Strategy 2016-2035 has evolved from previous global strategies to respond to old and new challenges and take advantage of new opportunities. It frames the global fight against TB as a development, social justice and human rights issue, while re-emphasizing the public health and clinical fundaments of TB care and prevention. In this commentary, we outline how TB prevention, care and control will both benefit from and contribute to the achievement of the new Sustainable Development Goals that were recently adopted at the United Nations. © The author 2016. The World Health Organization has granted Oxford University Press permission for the reproduction of this article.

Entities:  

Keywords:  Determinants; End TB Strategy; Social determinants; Social protection; Sustainable development goals; Tuberculosis

Mesh:

Year:  2016        PMID: 26884490      PMCID: PMC4755423          DOI: 10.1093/trstmh/trv108

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


Global development has entered a new era. World leaders are committing to ‘end poverty, promote prosperity and people's well-being while protecting the environment by 2030’.[1] Seventeen new Sustainable Development Goals (SDGs) were adopted at the United Nations Summit in September 2015. The SDG era began on 1 January 2016; at the same time that the WHO's new End TB Strategy to prevent, control and end the TB epidemic came into action.[2] The SDGs build on the unfinished Millennium Development Goals (MDGs) agenda, but with a broader scope and more ambitious targets. They cover three dimensions: economic, social and environmental. The SDGs are ‘Universal, indivisible and interlinked’, and the interdependence between health and development is clearly recognized. Health is seen as both a contributor to, and a beneficiary of, development and is therefore an integral part of all the SDGs. The overriding vision of the SDGs is that ‘all human beings can fulfil their potential in dignity and equality and in a healthy environment’ and ‘enjoy prosperous and fulfilling lives.’[1] The specific SDG ‘Health Goal’ (Goal No. 3) aims to ‘ensure healthy lives and promote well-being for all at all ages.’ In more detail, target No. 3.3 reads, ‘End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases’.[1] Translated into numerical targets this means that TB incidence and death rates should be reduced by 80% and 90%, respectively, in 15 years. The End TB Strategy has a longer timeline than the SDGs, up to 2035. Although the 80%/90% reduction represents 2030 milestones in the End TB Strategy, the targets are 90% incidence and 95% death rate reduction by 2035, which means that the global burden of TB should be similar to the burden in low-incidence countries today.[2] This is a substantial shift in ambition level compared to the MDG era (and the related global TB strategy), which aimed solely at reverting the previous upward incidence trend within a 15-year horizon. Although lumped into one ‘umbrella’ health goal only, the health scope in SDGs has been considerably broadened compared to the MDGs, now encompassing non-communicable diseases, health of the elderly, mental health, substance abuse, tobacco smoking, environmental health hazards, injuries and road traffic accidents.[1] There has been a true epidemiological transition in the minds behind the new health-related development goals. This is good news for TB care and prevention. The risk of diluting attention to TB by broadening the scope is less than the opportunities to jointly address TB risk factors and common health system bottlenecks.[2-5] Moreover, the radical shift in ambition level for the TB targets should ensure that there is no room for relaxing the effort. The WHO's End TB Strategy was developed in parallel with the SDGs, and efforts were made to align indicators and targets. The two stem from the same philosophy: multisectoral approaches are necessary and the root causes of human health despair must be addressed for sustainable impact. Both agendas are bold, responding to an appropriately grand vision and an urgent need for action. Many of the interventions necessary to reach the ambitious targets set out in the End TB Strategy should now be anchored in the SDGs, especially those that require prominent engagement outside the health sector, such as addressing the social and economic determinants of TB.[4,6] In short, the End TB Strategy targets cannot be achieved unless rapid and substantial progress is made towards the SDGs. Conversely, better TB care and prevention will help achieve the SDGs in several ways. A crucial health target is No 3.8: ‘Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all’.[1] TB coverage indicators (TB detection and treatment success) are part of the metrics to monitor progress towards this target, given they are recognized as an essential health intervention for a disease that disproportionately affects the poorest.[7] The End TB Strategy indicator on ‘catastrophic costs due to TB’ could complement monitoring of the progress towards social protection too.[8] In the background analysis for the SDGs, TB diagnosis and treatment were listed among the most cost-effective health interventions, and also one that directly contributes to improved productivity and, therefore, overall societal development.[9] Not by chance, The Economist ranked TB interventions as the top health measure and the sixth in the general list of ‘no brainers’ for development investments, based on estimated societal benefit per dollar spent for various development targets.[10] TB as contributor to development is thus well captured in the SDGs. It is not difficult to justify the fact that TB can also benefit from the SDG achievements. Examples of actions that would address key TB determinants[6] are clear-cut in the new goals: ending poverty in all its forms everywhere; ending hunger, achieving food security and improved nutrition, and promoting sustainable agriculture; ensuring inclusive and equitable quality education and promoting lifelong learning opportunities for all; achieving gender equality; ensuring access to affordable, reliable, sustainable and modern energy for all; reducing inequality within and among countries; and making cities and human settlements inclusive, safe, resilient and sustainable. One theme that could have been better emphasised in the SDGs is health research. Goal 9 includes to ‘… foster innovation’ and one of the Goal 3 targets is about ‘strengthening research for medicines and vaccines’. However, investments in broader health research, including epidemiology, social science and health systems research, and the required infrastructure, training and career paths are not clearly outlined. Without it, the path forward will be winding. The third pillar of the End TB strategy addresses this need, and a global action framework has been developed to foster its implementation, promote capacity building in TB endemic countries and stimulate multidisciplinary research along the continuum from basic science to operational research.[11] Now that the principles and standards have been established, we must ensure that the End TB strategy is fully rolled-out and goals are achieved. The challenges ahead are multiple, but one over-arching need is clear: both the SDGs and End TB Strategy implementation will require very active engagement of all sectors and partners, from the highest level government officials to civil society. This is why WHO makes a point of defining the target audience for the End TB Strategy in much broader terms than for previous global TB strategies. The question at this point is if stakeholders, especially those outside of the health sector, are ready to act rapidly and put the principles into practice. The SDGs promise to strengthen the required institutional, infrastructure and partnership foundations to make goals achievable. Goal 16 is to ‘Promote peaceful and inclusive societies for sustainable development, provide access to justice for all and build effective, accountable and inclusive institutions at all levels’, and Goal 17 is to ‘Strengthen the means of implementation and revitalize the global partnership for sustainable development’. The keywords are there: freedom, peace, security, human rights, rule of law, good governance, and commitment to just and democratic societies. It is up to all of us to contribute to the realization of this vision and sustain it. The ultimate goal of TB elimination (less than one TB case per million population) requires that appropriate interventions are implemented everywhere and the underlying drivers are not only addressed, but sustainably addressed.[12] History teaches us that epidemics re-emerge when neglect, ignorance and carelessness are let to prevaricate commitment, science and care.
  7 in total

1.  Tuberculosis control and elimination 2010-50: cure, care, and social development.

Authors:  Knut Lönnroth; Kenneth G Castro; Jeremiah Muhwa Chakaya; Lakhbir Singh Chauhan; Katherine Floyd; Philippe Glaziou; Mario C Raviglione
Journal:  Lancet       Date:  2010-05-22       Impact factor: 79.321

Review 2.  Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts.

Authors:  Ben J Marais; Knut Lönnroth; Stephen D Lawn; Giovanni Battista Migliori; Peter Mwaba; Philippe Glaziou; Matthew Bates; Ruth Colagiuri; Lynn Zijenah; Soumya Swaminathan; Ziad A Memish; Michel Pletschette; Michael Hoelscher; Ibrahim Abubakar; Rumina Hasan; Afia Zafar; Guiseppe Pantaleo; Gill Craig; Peter Kim; Markus Maeurer; Marco Schito; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2013-03-24       Impact factor: 25.071

Review 3.  Drivers of tuberculosis epidemics: the role of risk factors and social determinants.

Authors:  Knut Lönnroth; Ernesto Jaramillo; Brian G Williams; Christopher Dye; Mario Raviglione
Journal:  Soc Sci Med       Date:  2009-04-23       Impact factor: 4.634

4.  WHO's new end TB strategy.

Authors:  Mukund Uplekar; Diana Weil; Knut Lonnroth; Ernesto Jaramillo; Christian Lienhardt; Hannah Monica Dias; Dennis Falzon; Katherine Floyd; Giuliano Gargioni; Haileyesus Getahun; Christopher Gilpin; Philippe Glaziou; Malgorzata Grzemska; Fuad Mirzayev; Hiroki Nakatani; Mario Raviglione
Journal:  Lancet       Date:  2015-03-24       Impact factor: 79.321

Review 5.  Towards tuberculosis elimination: an action framework for low-incidence countries.

Authors:  Knut Lönnroth; Giovanni Battista Migliori; Ibrahim Abubakar; Lia D'Ambrosio; Gerard de Vries; Roland Diel; Paul Douglas; Dennis Falzon; Marc-Andre Gaudreau; Delia Goletti; Edilberto R González Ochoa; Philip LoBue; Alberto Matteelli; Howard Njoo; Ivan Solovic; Alistair Story; Tamara Tayeb; Marieke J van der Werf; Diana Weil; Jean-Pierre Zellweger; Mohamed Abdel Aziz; Mohamed R M Al Lawati; Stefano Aliberti; Wouter Arrazola de Oñate; Draurio Barreira; Vineet Bhatia; Francesco Blasi; Amy Bloom; Judith Bruchfeld; Francesco Castelli; Rosella Centis; Daniel Chemtob; Daniela M Cirillo; Alberto Colorado; Andrei Dadu; Ulf R Dahle; Laura De Paoli; Hannah M Dias; Raquel Duarte; Lanfranco Fattorini; Mina Gaga; Haileyesus Getahun; Philippe Glaziou; Lasha Goguadze; Mirtha Del Granado; Walter Haas; Asko Järvinen; Geun-Yong Kwon; Davide Mosca; Payam Nahid; Nobuyuki Nishikiori; Isabel Noguer; Joan O'Donnell; Analita Pace-Asciak; Maria G Pompa; Gilda G Popescu; Carlos Robalo Cordeiro; Karin Rønning; Morten Ruhwald; Jean-Paul Sculier; Aleksandar Simunović; Alison Smith-Palmer; Giovanni Sotgiu; Giorgia Sulis; Carlos A Torres-Duque; Kazunori Umeki; Mukund Uplekar; Catharina van Weezenbeek; Tuula Vasankari; Robert J Vitillo; Constantia Voniatis; Maryse Wanlin; Mario C Raviglione
Journal:  Eur Respir J       Date:  2015-04       Impact factor: 16.671

Review 6.  Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice.

Authors:  Knut Lönnroth; Gojka Roglic; Anthony D Harries
Journal:  Lancet Diabetes Endocrinol       Date:  2014-09       Impact factor: 32.069

Review 7.  Beyond UHC: monitoring health and social protection coverage in the context of tuberculosis care and prevention.

Authors:  Knut Lönnroth; Philippe Glaziou; Diana Weil; Katherine Floyd; Mukund Uplekar; Mario Raviglione
Journal:  PLoS Med       Date:  2014-09-22       Impact factor: 11.069

  7 in total
  55 in total

Review 1.  Undernutrition and Tuberculosis: Public Health Implications.

Authors:  Pranay Sinha; Juliana Davis; Lauren Saag; Christine Wanke; Padmini Salgame; Jackson Mesick; C Robert Horsburgh; Natasha S Hochberg
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

2.  Development and Validation of a Parsimonious Tuberculosis Gene Signature Using the digital NanoString nCounter Platform.

Authors:  Vaishnavi Kaipilyawar; Yue Zhao; Xutao Wang; Noyal M Joseph; Selby Knudsen; Senbagavalli Prakash Babu; Muthuraj Muthaiah; Natasha S Hochberg; Sonali Sarkar; Charles R Horsburgh; Jerrold J Ellner; W Evan Johnson; Padmini Salgame
Journal:  Clin Infect Dis       Date:  2022-09-29       Impact factor: 20.999

3.  Contribution of Smoking to Tuberculosis Incidence and Mortality in High-Tuberculosis-Burden Countries.

Authors:  Genet A Amere; Pratibha Nayak; Argita D Salindri; K M V Narayan; Matthew J Magee
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

4.  Modelling the impact of social protection on tuberculosis: the S-PROTECT project.

Authors:  D Boccia; W Rudgard; S Shrestha; K Lönnroth; P Eckhoff; J Golub; M Sanchez; E Maciel; D Rasella; P Shete; D Pedrazzoli; R Houben; S Chang; D Dowdy
Journal:  BMC Public Health       Date:  2018-06-26       Impact factor: 3.295

Review 5.  Food for thought: addressing undernutrition to end tuberculosis.

Authors:  Pranay Sinha; Knut Lönnroth; Anurag Bhargava; Scott K Heysell; Sonali Sarkar; Padmini Salgame; William Rudgard; Delia Boccia; Daniel Van Aartsen; Natasha S Hochberg
Journal:  Lancet Infect Dis       Date:  2021-03-23       Impact factor: 25.071

6.  The global burden of tuberculosis: results from the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet Infect Dis       Date:  2017-12-07       Impact factor: 71.421

7.  The impact of rural residence and HIV infection on poor tuberculosis treatment outcomes in a large urban hospital: a retrospective cohort analysis.

Authors:  Aishatu Lawal Adamu; Muktar H Aliyu; Najiba Aliyu Galadanci; Baba Maiyaki Musa; Umar Muhammad Lawan; Usman Bashir; Ibrahim Abubakar
Journal:  Int J Equity Health       Date:  2018-01-08

8.  Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data.

Authors:  Jennifer M Ross; Anani Badje; Molebogeng X Rangaka; A Sarah Walker; Adrienne E Shapiro; Katherine K Thomas; Xavier Anglaret; Serge Eholie; Delphine Gabillard; Andrew Boulle; Gary Maartens; Robert J Wilkinson; Nathan Ford; Jonathan E Golub; Brian G Williams; Ruanne V Barnabas
Journal:  Lancet HIV       Date:  2021-01       Impact factor: 12.767

9.  Challenges in delivery of tuberculosis Services in Ethiopian Pastoralist Settings: clues for reforming service models and organizational structures.

Authors:  Fentabil Getnet; Meaza Demissie; Alemayehu Worku; Tesfaye Gobena; Rea Tschopp; Alinoor Mohamed Farah; Berhanu Seyoum
Journal:  BMC Health Serv Res       Date:  2021-06-30       Impact factor: 2.655

10.  Collaborative Approaches and Policy Opportunities for Accelerated Progress toward Effective Disease Prevention, Care, and Control: Using the Case of Poverty Diseases to Explore Universal Access to Affordable Health Care.

Authors:  Samia Laokri
Journal:  Front Med (Lausanne)       Date:  2017-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.